Cargando…
Chemotherapeutic xCT inhibitors sorafenib and erastin unraveled with the synaptic optogenetic function analysis tool
In the search for new potential chemotherapeutics, the compounds’ toxicity to healthy cells is an important factor. The brain with its functional units, the neurons, is especially endangered during the radio- and chemotherapeutic treatment of brain tumors. The effect of the potential compounds not o...
Autores principales: | Dahlmanns, Marc, Yakubov, Eduard, Chen, Daishi, Sehm, Tina, Rauh, Manfred, Savaskan, Nicolai, Wrosch, Jana Katharina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541984/ https://www.ncbi.nlm.nih.gov/pubmed/28835855 http://dx.doi.org/10.1038/cddiscovery.2017.30 |
Ejemplares similares
-
Temozolomide toxicity operates in a xCT/SLC7a11 dependent manner and is fostered by ferroptosis
por: Sehm, Tina, et al.
Publicado: (2016) -
Ferroptosis and PPAR-gamma in the limelight of brain tumors and edema
por: Yakubov, Eduard, et al.
Publicado: (2023) -
The structure of erastin-bound xCT–4F2hc complex reveals molecular mechanisms underlying erastin-induced ferroptosis
por: Yan, Renhong, et al.
Publicado: (2022) -
Dexamethasone Alleviates Tumor-Associated Brain Damage and Angiogenesis
por: Fan, Zheng, et al.
Publicado: (2014) -
Erastin/sorafenib induces cisplatin-resistant non-small cell lung cancer cell ferroptosis through inhibition of the Nrf2/xCT pathway
por: Li, Yu, et al.
Publicado: (2020)